Next Article in Journal
Identification and Characterization of MortaparibPlus—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
Next Article in Special Issue
Type I and II Interferons in the Anti-Tumor Immune Response
Previous Article in Journal
How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature
Previous Article in Special Issue
A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics
 
 
Review

Article Versions Notes

Cancers 2021, 13(4), 837; https://doi.org/10.3390/cancers13040837
Action Date Notes Link
article xml file uploaded 17 February 2021 10:55 CET Original file -
article xml uploaded. 17 February 2021 10:55 CET Update https://www.mdpi.com/2072-6694/13/4/837/xml
article pdf uploaded. 17 February 2021 10:55 CET Version of Record https://www.mdpi.com/2072-6694/13/4/837/pdf
article html file updated 17 February 2021 10:56 CET Original file -
article html file updated 25 July 2022 03:48 CEST Update https://www.mdpi.com/2072-6694/13/4/837/html
Back to TopTop